The following adjustment was made today on Novartis (NVS). All prices include IB commissions.
This is the second position on NVS.
Criteria | Value |
Dividend Champions Status | Contender |
Years of Consecutive Dividend Increases | 10 |
Fair Value Estimate | $69.00* |
Target Buy Price | $55.20 |
Target Margin of Safety | 20.00% |
Actual Buy Price | $52.50 |
Actual Margin of Safety | 23.91% |
*Fair Value was lowered from $71 to $69 since inception which lowered my 26.06% Margin of Safety to 23.91%.
Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
7/27/2012 | NVS | Continued Trade | STO 1 Sep12 60.00 Call @ 0.54 |   |   | $54.25 |
Current Position Summary
Cost Basis | ($5,500.00) |
Income Generated | $192.19 |
Percent Income Generated | 3.49% |
Annualized Income Generated | 6.02% |
Net Profit If Assigned | $692.19 |
Percent Return If Assigned | 12.59% |
Annualized Return If Assigned | 21.67% |
Days Held to Expiration | 212 days |
Trade History
Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
2/22/2012 | NVS | CSP Margin Used | CSP 100 NVS @ 55.00 |   | ($5,500.00) |   |
2/22/2012 | NVS | Initial Put Option | STO 1 Mar12 55.00 Put @ 0.79 | Exercised |   | $78.97 |
3/16/2012 | NVS | CSP Margin Returned | CSP 100 NVS @ -55.00 |   | $5,500.00 |   |
3/16/2012 | NVS | Stock Assigned | EX 1 Mar12 55.00 Put @ -55.00 |   | ($5,500.00) |   |
3/19/2012 | NVS | Continued Trade | STO 1 May12 57.50 Call @ 0.59 | Expired |   | $58.97 |
7/27/2012 | NVS | Continued Trade | STO 1 Sep12 60.00 Call @ 0.54 |   |   | $54.25 |
9/21/2012 | NVS |   | Totals |   | ($5,500.00) | $192.19 |
DTE | 212 |   | Percent Income/Annualized |   | 3.49% | 6.02% |